Samil exclusively to distribute UCB Korea prescription drugs.

Published: 2006-09-05 06:57:00

Updated: 2006-09-05 06:57:00

Samil Pharmaceutical company will distribute all UCB Korea prescription drugs in Korea according to the logistic and distribution agreement between Samil and UCB Korea dated on Aug. 31.

The agreement shall be renewed automatically, covering that Samil shall have logistic responsibilities for t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK